Steel Grove Capital Advisors LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 19.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,722 shares of the exchange traded fund’s stock after selling 1,610 shares during the period. Steel Grove Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $623,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently bought and sold shares of the business. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after buying an additional 730,000 shares during the period. Mirae Asset Securities USA Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at $55,626,000. Jane Street Group LLC grew its holdings in shares of SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after acquiring an additional 391,333 shares in the last quarter. Finally, Baymount Management LP acquired a new position in shares of SPDR S&P Biotech ETF in the first quarter worth $34,160,000.
SPDR S&P Biotech ETF Trading Down 0.8 %
Shares of NYSEARCA:XBI opened at $101.61 on Monday. The firm has a market cap of $7.74 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The business has a fifty day simple moving average of $99.03 and a 200 day simple moving average of $93.90.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- See Why Oracle’s Cloud Infrastructure Growth Demands Attention
- The 3 Best Blue-Chip Stocks to Buy Now
- Darden Restaurants Is on the Verge of a Significant Breakout
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Onsemi Could Be Set Up For a Solid Rebound: Here’s Why
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.